Johnson, B. A., Baban, B., & Mellor, A. L. (2009). Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.
Chicago Style CitationJohnson, Burles A., Babak Baban, i Andrew L. Mellor. Targeting the Immunoregulatory Indoleamine 2,3 Dioxygenase Pathway in Immunotherapy. 2009.
Cita MLAJohnson, Burles A., Babak Baban, i Andrew L. Mellor. Targeting the Immunoregulatory Indoleamine 2,3 Dioxygenase Pathway in Immunotherapy. 2009.
Atenció: Aquestes cites poden no estar 100% correctes.